medigraphic.com
ISSN 1561-3119 (Digital)

2013, Número 3

<< Anterior Siguiente >>

Rev Cubana Pediatr 2013; 85 (3)


Recomendaciones para el tratamiento de urgencia de las taquicardias supraventriculares en edad pediátrica

Carballés GJF, Dopazo AMV, Rodríguez OW, González GSA, Medina GG, Palenzuela LH

Idioma: Español
Referencias bibliográficas: 33
Paginas:
Archivo PDF: 78.34 Kb.


RESUMEN

Las taquicardias supraventriculares son las arritmias sintomáticas más comunes en edad pediátrica. Obedecen a diferentes condiciones fisiopatológicas que resultan en patrones electrocardiográficos semejantes. Como el mecanismo de la arritmia durante la urgencia es con frecuencia desconocido, el tratamiento agudo al niño que se presenta en esta condición, puede ser un reto. Sin embargo, la estrategia de tratamiento depende fundamentalmente del estado clínico del paciente en el momento de la presentación, y no de una apreciación electrocardiográfica sujeta a errores. El presente artículo tiene el propósito de incrementar los conocimientos acerca de las taquicardias supraventriculares entre los médicos vinculados a la atención pediátrica, mediante una revisión, que enfocada en la edad, trata sus presentaciones más frecuentes, aspectos del diagnóstico y el tratamiento.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Jat KR, Lodha R, Kabra SK. Arrhythmias in children. Indian J Pediatr. 2011;78(2):211-8.

  2. Salerno JC, Seslar SP. Supraventricular tachycardia. Arch Pediatr Adolesc Med. 2009;163(3):268-74.

  3. Vignati G, Annoni G. Characterization of supraventricular tachycardia in infants: clinical and instrumental diagnosis. Curr Pharm Des. 2008;14(8):729-35.

  4. Balaguer Gargallo M, Jordán García I, Caritg Bosch J, Cambra Lasaosa FJ, Prada Hermogenes F, Palomaque Rico A. Supraventricular tachycardia in infants and children. An Pediatr (Barc). 2007;67(2):133-8.

  5. Schlechte EA, Boramanand N, Funk M. Supraventricular tachycardia in the pediatric primary care setting: Age-related presentation, diagnosis, and management. J Pediatr Health Care. 2008;22(5):289-99.

  6. Calabrò MP, Cerrito M, Luzza F, Oreto G. Supraventricular tachycardia in infants: epidemiology and clinical management. Curr Pharm Des. 2008;14(8):723-8.

  7. Manole MD, Saladino RA. Emergency department management of the pediatric patient with supraventricular tachycardia. Pediatr Emerg Care. 2007;23(3):176-85.

  8. Novo S, Barbaro G. Current trends in the treatment of supraventricular tachycardia in pediatric age. Curr Pharm Des. 2008;14(8):722.

  9. Paul T, Bertram H, Kriebel T, Windhagen-Mahnert B, Tebbenjohanns J, Hausdorf G. Supraventricular tachycardia in infants, children and adolescents: diagnosis, drug and interventional therapy. Z Kardiol. 2000;89(6):546-58.

  10. Anand RG, Rosenthal GL, Van Hare GF, Snyder CS. Is the mechanism of supraventricular tachycardia in pediatrics influenced by age, gender or ethnicity? Congenit Heart Dis. 2009;4(6):464-8.

  11. Blaufox AD, Warsy I, D'Souza M, Kanter R. Transesophageal electrophysiological evaluation of children with a history of supraventricular tachycardia in infancy. Pediatr Cardiol. 2011;32(8):1110-4.

  12. Wellens HJ, Smeets JL, Rodríguez LM, Timmermans C. Are there still indications for pharmacological treatment in patients with AV reentry tachycardias with and without accessory AV pathways? En: Farré J, Moro C, eds. Ten years of radiofrequency catheter ablation. New York: Futura Publishing Co. Inc; 1998. p. 43-8.

  13. Valderrama AL. Wolff-Parkinson-White syndrome: Essentials for the primary care nurse practitioner. Journal of the American Academy of Nurse Practitioners. 2004;16:378-83.

  14. Juneja R, Shah S, Naik N, Kothari SS, Saxena A, Talwar KK. Management of cardiomyopathy resulting from incessant supraventricular tachycardia in infants and children. Indian Heart J. 2002;54(2):176-80.

  15. Merino JL. Ablación de la taquicardia intranodal: cuando la fisiología cuenta en la era de la anatomía. Rev Esp Cardiol. 2007;60:7-9.

  16. Doniger SJ, Sharieff GQ. Pediatric dysrhythmias. Pediatric Clinics of North America. 2006;53:85-105.

  17. Kantoch MJ. Supraventricular tachycardia in children. Indian Journal of Pediatrics. 2005;72:609-19.

  18. Brady W. Pediatric dysrhythmias. Early recognition and management. [homepage en Internet] Noviembre; 2009 [citado 10 de agosto 2012] Disponible en: http://www.vdh.virginia.gov/OEMS/Files-page/symposium/2009Presentation/SPE- 1010.pdf

  19. Gilljam T, Jaeggi E, Gow RM. Neonatal supraventricular tachycardia: outcomes over a 27-year period at a single institution. Acta Paediatr. 2008;97(8):1035-9.

  20. Jaeggi ET, Gilljam T, Bauersfeld U. Electrocardiographic differentiation of typical atrioventricular node reentrant tachycardia from atrioventricular reciprocating tachycardia mediated by concealed accessory pathway in children. Am J Cardiol. 2003;91:1084.

  21. Di Pino A, Caruso E, Salvo D, Bianca I. Clinical and electrophysiological characteristics, and relatively benign outcome, of typical atrioventricular nodal reentrant tachycardia in children and adolescents. Cardiol Young. 2008;18(5):512-9.

  22. Liberman L, Pass RH, Starc TJ. Optimal surface electrocardiogram lead for identification of the mechanism of supraventricular tachycardia in children. Pediatr Emerg Care. 2008;24(1):28-30.

  23. Dubin AM. Supraventricular tachycardia in children: AV reentrant tachycardia (including WPW) and AV nodal reentrant tachycardia. [homepage en Internet] Noviembre; 2012 [citado 12 de agosto 2012]. Disponible en:http://www.uptodate.com/contents/supraventricular-tachycardia-in-children-avreentrant- tachycardia-including -wpw-and-av-nodal-reentranttachycardia? source=search_result&search=Dubin+AM.+Supraventricular+tachycardia +in+children%3A+AV+reentrant+tachycardia+%28including+WPW%29+and+AV+nod al+reentrant+tachycardia&selectedTitle=1~150

  24. Ganz LI. Epidemiology of and risk factors for atrial fibrillation. Clinicians Institutions Group Practices Patients.[homepage en Internet] Abril; 2013 [citado 12 de agosto 2012]. Disponible en:http://www.uptodate.com/contents/epidemiology-of - and-risk-factors-for-atrialfibrillation? topicKey=CARD%2F1004&elapsedTimeMs=4&source=search_result&search Term=Ganz+LI.+Epidemiology+of+and+risk+factors+for+atrial+fibrillation.+Clinician s+Institutions+Group+Practices+Patients.+Citado+Feb%2C+2012&selectedTitle=1~1 50&view=print&displayedView=full

  25. Ganz LI. Atrial flutter: Epidemiology, classification, and risk factors Patients. [homepage en Internet] Abril; 2013 [citado 12 de agosto 2012]. Disponible en: http://www.uptodate.com/contents/epidemiology-of-and-risk -factors-for-atrialfibrillation? detectedLanguage=en&source=search_result&search=atrial+flutter+epide miology+classification+and+risk+factors&selectedTitle=9~143&provider=noProvider

  26. Dubin AM. Management of supraventricular tachycardia in children. [homepage en Internet] Marzo; 2013 [citado 12 de agosto 2012]. Disponible en: http://www.uptodate.com/contents/management-of-supraventricular-tachycardiain - children?source=search_result&search=Dubin+AM.+Management+of+supraventricular +tachycardia+in+children.+Citado+Oct%2C+2011&selectedTitle=1~150

  27. Shilkofski NA, Nelson KL, Hunt EA. Recognition and treatment of unstable supraventricular tachycardia by pediatric residents in a simulation scenario. Simul Healthc. 2008;3(1):4-9.

  28. Connor S. Treatment of supraventricular tachycardia with adenosine in children: size does matter. Emerg Med J. 2009;26(12):911-2.

  29. Bouhouch R, El Houari T, Fellat I, Arharbi M. Pharmacological therapy in children with nodal reentry tachycardia: when, how and how long to treat the affected patients. Curr Pharm Des. 2008;14(8):766-9.

  30. Chang PM, Silka MJ, Moromisato DY, Bar-Cohen Y. Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients. Circ Arrhythm Electrophysiol. 2010;3(2):134-40.

  31. Dilber E, Mutlu M, Dilber B, Aslan Y, Gedik Y, Celiker A. Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants. Pediatr Emerg Care. 2010; 26(2):82-4.

  32. Saul JP, LaPage MJ. Is it time to tell the emperor he has no clothes?: Intravenous amiodarone for supraventricular arrhythmias in children. Circ Arrhythm Electrophysiol. 2010;3(2):115-7.

  33. Tafil NM, Benner KW, Zinkan L, Alten J, Varisco BM, White ML. Pediatric intensive care simulation course: a new paradigm in teaching. J Grad Med Educ. 2011;3(1):81- 7.




2020     |     www.medigraphic.com